JP Morgan Chase
ANGO icon

JP Morgan Chase’s AngioDynamics ANGO Stock Holding History

JP Morgan Chase’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178K Buy
16,400
+145
+0.9% +$1.57K ﹤0.01% 5531
2025
Q4 		$209K Sell
16,255
-658
-4% -$8.12K ﹤0.01% 5521
2025
Q3 		$189K Sell
16,913
-55,503
-77% -$536K ﹤0.01% 5550
2025
Q2 		$718K Sell
72,416
-253,681
-78% -$2.48M ﹤0.01% 4577
2025
Q1 		$3.06M Sell
326,097
-481,386
-60% -$5.06M ﹤0.01% 3559
2024
Q4 		$7.4M Buy
807,483
+254,322
+46% +$1.87M ﹤0.01% 2999
2024
Q3 		$4.3M Buy
553,161
+123,271
+29% +$890K ﹤0.01% 3323
2024
Q2 		$2.6M Sell
429,890
-234,013
-35% -$1.44M ﹤0.01% 3559
2024
Q1 		$3.9M Sell
663,903
-41,619
-6% -$247K ﹤0.01% 3311
2023
Q4 		$5.53M Buy
705,522
+113,707
+19% +$789K ﹤0.01% 2987
2023
Q3 		$4.33M Buy
591,815
+167,015
+39% +$1.39M ﹤0.01% 2941
2023
Q2 		$4.43M Buy
424,800
+195,102
+85% +$1.88M ﹤0.01% 2955
2023
Q1 		$2.38M Sell
229,698
-123,382
-35% -$1.58M ﹤0.01% 3424
2022
Q4 		$4.86M Sell
353,080
-49,227
-12% -$685K ﹤0.01% 2842
2022
Q3 		$8.23M Buy
402,307
+34,507
+9% +$758K ﹤0.01% 2311
2022
Q2 		$7.12M Sell
367,800
-1,515
-0.4% -$31K ﹤0.01% 2450
2022
Q1 		$7.96M Buy
369,315
+97,632
+36% +$2.22M ﹤0.01% 2601
2021
Q4 		$7.49M Sell
271,683
-22,217
-8% -$613K ﹤0.01% 2698
2021
Q3 		$7.62M Buy
293,900
+3,911
+1% +$105K ﹤0.01% 2654
2021
Q2 		$7.87M Buy
289,989
+142,332
+96% +$3.48M ﹤0.01% 2647
2021
Q1 		$3.46M Sell
147,657
-146,411
-50% -$2.96M ﹤0.01% 3285
2020
Q4 		$4.51M Buy
294,068
+86,417
+42% +$1.1M ﹤0.01% 2895
2020
Q3 		$2.65M Sell
207,651
-22,470
-10% -$213K ﹤0.01% 3036
2020
Q2 		$2.34M Sell
230,121
-129,530
-36% -$1.33M ﹤0.01% 3004
2020
Q1 		$3.75M Buy
359,651
+58,944
+20% +$740K ﹤0.01% 2499
2019
Q4 		$4.81M Sell
300,707
-63,835
-18% -$975K ﹤0.01% 2706
2019
Q3 		$6.71M Buy
364,542
+48,378
+15% +$946K ﹤0.01% 2446
2019
Q2 		$6.16M Sell
316,164
-207,551
-40% -$4.23M ﹤0.01% 2475
2019
Q1 		$12M Sell
523,715
-21,818
-4% -$474K ﹤0.01% 1893
2018
Q4 		$11M Sell
545,533
-78,832
-13% -$1.63M ﹤0.01% 1940
2018
Q3 		$13.6M Sell
624,365
-144,858
-19% -$3.22M ﹤0.01% 1954
2018
Q2 		$17.1M Sell
769,223
-126,191
-14% -$2.58M ﹤0.01% 1713
2018
Q1 		$15.4M Buy
895,414
+810,794
+958% +$13.5M ﹤0.01% 1704
2017
Q4 		$1.41M Sell
84,620
-20,241
-19% -$345K ﹤0.01% 3530
2017
Q3 		$1.71M Buy
104,861
+26,761
+34% +$450K ﹤0.01% 3245
2017
Q2 		$1.27M Sell
78,100
-305,778
-80% -$4.83M ﹤0.01% 3305
2017
Q1 		$6.66M Sell
383,878
-78,505
-17% -$1.31M ﹤0.01% 2228
2016
Q4 		$7.8M Buy
462,383
+173,658
+60% +$2.9M ﹤0.01% 2097
2016
Q3 		$5.07M Buy
288,725
+50
+0% +$811 ﹤0.01% 2248
2016
Q2 		$4.15M Sell
288,675
-350
-0.1% -$4.37K ﹤0.01% 2409
2016
Q1 		$3.55M Buy
+289,025
New +$3.19M ﹤0.01% 2398
2014
Q3 		– Sell
-25,346
Closed -$414K – 4173
2014
Q2 		$414K Buy
+25,346
New +$367K ﹤0.01% 3176
2014
Q1 		– Sell
-12,383
Closed -$213K – 3574
2013
Q4 		$213K Sell
12,383
-23,167
-65% -$357K ﹤0.01% 3802
2013
Q3 		$469K Buy
35,550
+17,323
+95% +$204K ﹤0.01% 3668
2013
Q2 		$205K Buy
+18,227
New +$194K ﹤0.01% 3976

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

JP Morgan Chase's ANGO Position: Q1 2026 in Review

JP Morgan Chase increased its AngioDynamics (ANGO) stake by 0.89% in Q1 2026, buying an estimated $1.57K and bringing the position to 16,400 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #5531.

JP Morgan Chase first reported a position in ANGO in Q2 2013 and has held it in 45 quarters since. The position peaked at $17.1M in Q2 2018. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • JP Morgan Chase held 16,400 shares of AngioDynamics worth $178K as of Q1 2026.
  • JP Morgan Chase bought 145 AngioDynamics shares in Q1 2026, an estimated $1.57K.
  • AngioDynamics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5531 holding.
  • JP Morgan Chase first reported a position in AngioDynamics in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's AngioDynamics position peaked at $17.1M in Q2 2018.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.